博拓生物：青石永隽聚焦于垂直医疗领域

Core Viewpoint - Both Neuralink and Qingstone Yongjun are focused on invasive brain-machine interface technology, but they have distinct core objectives and approaches [1] Group 1: Company Comparison - Neuralink aims to create a comprehensive "whole-brain interface" that integrates multiple functions such as movement, language, and vision, with the ultimate goal of deep integration with artificial intelligence and achieving human-AI coexistence [1] - Qingstone Yongjun, on the other hand, concentrates on the vertical medical field, specifically targeting the treatment of treatment-resistant severe depression with its first product, which offers personalized treatment plans through a closed-loop control system [1] - The technological approach of Neuralink is characterized by platformization and generalization, while Qingstone Yongjun seeks to excel in specific brain disease treatment scenarios [1]